UK – GSK’s Blenrep combination recommended by NICE to treat multiple myeloma
GSK’s Blenrep (belantamab mafodotin) has been recommended by the National Institute for Health and Care Excellence (NICE) as part of a combination treatment for multiple myeloma (MM). The health technology assessment agency has recommended in...





